ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,659.81
      0.51%
      US Tech 100
      19,826.00
      -0.10%
      Dow Jones
      40,938.59
      1.81%
      Brent Oil
      83.245
      -1.30%
      Bitcoin
      64,937.24
      0.13%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Johnson and Johnson (JNJ)

      7. Johnson and Johnson (JNJ) News

      JNJ

      Johnson and Johnson (JNJ)

      Johnson and Johnson
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:JNJ
      DateTimeSourceHeadlineSymbolCompany
      11/12/20216:30AMPR Newswire (US)Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health BusinessNYSE:JNJJohnson and Johnson
      11/10/20215:14PMPR Newswire (US)Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian BufferNYSE:JNJJohnson and Johnson
      11/09/20214:30PMPR Newswire (US)Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health AwardsNYSE:JNJJohnson and Johnson
      11/09/202111:16AMDow Jones NewsAlkermes Shares Slide as J&J Moves to End Some Royalty PaymentsNYSE:JNJJohnson and Johnson
      10/29/20214:08PMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:JNJJohnson and Johnson
      10/28/20215:15PMDow Jones NewsBankruptcy Administrator Seeks Formation of J&J Talc Claimant CommitteeNYSE:JNJJohnson and Johnson
      10/21/20217:48PMPR Newswire (US)U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 VaccinesNYSE:JNJJohnson and Johnson
      10/21/20212:38PMPR Newswire (US)Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021NYSE:JNJJohnson and Johnson
      10/21/20218:46AMTipRanksJohnson & Johnson’s COVID-19 Vaccine Booster Dose Cleared for Emergency Use in U.S.NYSE:JNJJohnson and Johnson
      10/20/20216:38PMPR Newswire (US)Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDANYSE:JNJJohnson and Johnson
      10/20/20218:58AMDow Jones NewsF-star Therapeutics Shares Up 9% Premarket After Janssen Biotech DealNYSE:JNJJohnson and Johnson
      10/20/202112:57AMTipRanksJohnson & Johnson Posts Mixed Q3 Results; Shares Rise 2.3%NYSE:JNJJohnson and Johnson
      10/19/20218:02AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:JNJJohnson and Johnson
      10/19/20217:15AMDow Jones NewsJohnson & Johnson Posts 3Q Earnings Growth as Sales Grow Across DivisionsNYSE:JNJJohnson and Johnson
      10/19/20217:13AMDow Jones NewsJohnson & Johnson Raises Full-Year Adjusted-Earnings GuidanceNYSE:JNJJohnson and Johnson
      10/19/20216:25AMPR Newswire (US)Johnson & Johnson Reports Q3 2021 ResultsNYSE:JNJJohnson and Johnson
      10/18/20218:27AMTipRanksJohnson & Johnson’s Booster Dose for COVID-19 Gets Green LightNYSE:JNJJohnson and Johnson
      10/15/20214:11PMPR Newswire (US)Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory CommitteeNYSE:JNJJohnson and Johnson
      10/15/20219:09AMDow Jones NewsPro Bankruptcy Briefing: J&J Unit Files Bankruptcy Over Talc Claims; Purdue Appeals to Be HeardNYSE:JNJJohnson and Johnson
      10/14/202110:38PMPR Newswire (US)Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy SchemeNYSE:JNJJohnson and Johnson
      10/14/20215:55PMPR Newswire (US)Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc ClaimsNYSE:JNJJohnson and Johnson
      10/13/20216:45AMPR Newswire (US)Johnson & Johnson to Host Business Review Highlighting PharmaceuticalsNYSE:JNJJohnson and Johnson
      10/12/20214:50PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:JNJJohnson and Johnson
      10/12/20214:15PMPR Newswire (US)Johnson & Johnson Announces Jessica Moore as Vice President of Investor RelationsNYSE:JNJJohnson and Johnson
      10/12/20216:45AMPR Newswire (US)Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021NYSE:JNJJohnson and Johnson
      10/11/20214:45PMPR Newswire (US)Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare ConferenceNYSE:JNJJohnson and Johnson
      10/08/20218:48AMDow Jones NewsJohnson & Johnson Unit Seeks FDA OK of Stelara for Juvenile Psoriatic ArthritisNYSE:JNJJohnson and Johnson
      10/07/20216:24AMFinscreener.org3 Large-Cap Oversold Stocks to Watch Out ForNYSE:JNJJohnson and Johnson
      10/06/202111:50AMDow Jones NewsJ&J's Janssen Moving Dengue Program Into Clinical DevelopmentNYSE:JNJJohnson and Johnson
      10/06/202111:00AMPR Newswire (US)Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in NatureNYSE:JNJJohnson and Johnson
       Showing the most relevant articles for your search:NYSE:JNJ